1. Home
  2. HALO vs NCLH Comparison

HALO vs NCLH Comparison

Compare HALO & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$62.28

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Logo Norwegian Cruise Line Holdings Ltd.

NCLH

Norwegian Cruise Line Holdings Ltd.

HOLD

Current Price

$20.86

Market Cap

10.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
NCLH
Founded
1998
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
10.7B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
HALO
NCLH
Price
$62.28
$20.86
Analyst Decision
Buy
Buy
Analyst Count
12
18
Target Price
$73.33
$28.89
AVG Volume (30 Days)
2.4M
15.3M
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
56.68
11.76
EPS
4.74
1.40
Revenue
$1,242,852,000.00
$9,692,558,000.00
Revenue This Year
$34.83
$6.85
Revenue Next Year
$24.84
$10.76
P/E Ratio
$13.14
$14.93
Revenue Growth
31.19
3.59
52 Week Low
$46.26
$14.21
52 Week High
$79.50
$29.29

Technical Indicators

Market Signals
Indicator
HALO
NCLH
Relative Strength Index (RSI) 34.09 62.86
Support Level $61.23 $18.51
Resistance Level $63.26 $19.23
Average True Range (ATR) 2.42 0.63
MACD -0.79 0.42
Stochastic Oscillator 7.60 86.83

Price Performance

Historical Comparison
HALO
NCLH

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: